| Name | Title | Contact Details |
|---|
Cayenne Medical is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BMP Medical is your preferred source for custom OEM injection molded medical devices. We are a privately held, veteran-owned company that has been in business for over 30 years. We use the most state of the art molding techniques and machinery to produce small to medium sized parts with very tight specifications. We also offer design consultation, engineering, drawing, R&D, tooling, mold development, computer automation, and statistical process control for mid-tier products. For our customer`s convenience, our facility is equipped with a Class 8 clean room for manufacturing, packaging, and assembly needs. BMP Medical has built its reputation on relationships and many of our OEM medical contract manufacturing customers have been with us for over 20 years. We look forward to introducing ourselves to new customers and building new relationships.
C.T.M. HOMECARE PRODUCT is a Eugene, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
C. R. Bard is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialties. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. Bard pioneered the development of single-patient-use medical products for hospital procedures; today Bard is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall health care costs.
At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.